TABLE OF CONTENTS
Volume 67, Issue S93 (January 2005)
Original Articles
Introduction
JOSÉ LUÑO, LUISMIGUEL RUILOPE and EBERHARD RITZ
Kidney Int 67: S1-S2; doi:10.1111/j.1523-1755.2005.09301.x
Predictive cardiovascular risk factors in patients with chronic kidney disease (CKD)
MARIAN GOICOECHEA, SOLEDAD GARCÍA DE VINUESA, FRANCISCO GÓMEZ-CAMPDERÁ and JOSÉ LUÑO
Kidney Int 67: S35-S38; doi:10.1111/j.1523-1755.2005.09308.x
ACE inhibitors improve nephrin expression in Zucker rats with glomerulosclerosis
SANDRA BLANCO, JOSEP BONET, DOLORES LÓPEZ, IRMA CASAS and RAMÓN ROMERO
Kidney Int 67: S10-S14; doi:10.1111/j.1523-1755.2005.09303.x
Baseline predictors of end-stage renal disease risk in patients with type 2 diabetes and nephropathy: New lessons from the RENAAL Study
SHAHNAZ SHAHINFAR, TANYA DICKSON, ZHONGXIN ZHANG, WILLIAM F KEANE and BARRY M BRENNER RENAAL I
Kidney Int 67: S48-S51; doi:10.1111/j.1523-1755.2005.09311.x
Microalbuminuria in hypertensive patients: Evaluation of one-year treatment with irbesartan
FERNANDO DE ÁLVARO, OLGA VELASCO, JESÚS HONORATO, CARLOS CALVO and INMA PARRONDO B
Kidney Int 67: S29-S34; doi:10.1111/j.1523-1755.2005.09307.x
Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria
ANDREW J PALMER, LIEVEN ANNEMANS, STÉPHANE ROZE, PABLO LAPUERTA, ROLAND CHEN, SYLVIE GABRIEL, PAULO CARITA, ROGER A RODBY, DICK DE ZEEUW, HANS-HENRIK PARVING and FERNANDO DE ALVARO
Kidney Int 67: S52-S54; doi:10.1111/j.1523-1755.2005.09312.x
AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II
EVA CEDIEL, NATALIA DE LAS HERAS, DAVID SANZ-ROSA, OLGA VELASCO, VICTORIA CACHOFEIRO and VICENTE LAHERA
Kidney Int 67: S3-S9; doi:10.1111/j.1523-1755.2005.09302.x
Is it the agent or the blood pressure level that matters for renal and vascular protection in chronic nephropathies?
FRANCESCO LOCATELLI, LUCIA DEL VECCHIO, PIETRO POZZONI, MARCO D'AMICO and SIMEONE ANDRULLI
Kidney Int 67: S15-S19; doi:10.1111/j.1523-1755.2005.09304.x
Cardiovascular risk profile in patients treated with sirolimus after renal transplantation
JOSÉ M MORALES
Kidney Int 67: S69-S73; doi:10.1111/j.1523-1755.2005.09315.x
Efficacy of moxonidine in the treatment of hypertension in obese, noncontrolled hypertensive patients
JOSÉ ABELLÁN, MARIANO LEAL, FERNANDO HERNÁNDEZ-MENÁRGUEZ, JOSÉ A GARCÍA-GALBIS, ANTONIO MARTÍNEZ-PASTOR, SOLEDAD GARCIA DE VINUESA and JOSÉ LUÑO
Kidney Int 67: S20-S24; doi:10.1111/j.1523-1755.2005.09305.x
Interdialytic weight gain as a marker of blood pressure, nutrition, and survival in hemodialysis patients
JUAN M LÓPEZ-GÓMEZ, MAITE VILLAVERDE, ROSA JOFRE, PATROCINIO RODRIGUEZ-BENÍTEZ and RAFAEL PÉREZ-GARCÍA
Kidney Int 67: S63-S68; doi:10.1111/j.1523-1755.2005.09314.x
Subclinical peripheral arterial disease in patients with chronic kidney disease: Prevalence and related risk factors
SOLEDAD GARCIA DE VINUESA, MAYRA ORTEGA, PATRICIA MARTINEZ, MARIAN GOICOECHEA, FRANCISCO GOMEZ CAMPDERA and JOSE LUÑO
Kidney Int 67: S44-S47; doi:10.1111/j.1523-1755.2005.09310.x
Cardiovascular risk factors in type 2 diabetic patients: Multifactorial intervention in primary care
SALVADOR TRANCHE, ALBERTO GALGO, XAVIER MUNDET and MIGUEL ANGEL SÁNCHEZ-ZAMORANO B
Kidney Int 67: S55-S62; doi:10.1111/j.1523-1755.2005.09313.x
Renal dysfunction as a novel risk factor: Microalbuminuria and cardiovascular risk
EBERHARD RITZ
Kidney Int 67: S25-S28; doi:10.1111/j.1523-1755.2005.09306.x
